Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2024-09.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96
1Clinical Trial Center, Ewha Womans University Mokdong Hospital, Seoul, Korea
2National Cancer Control Institute, National Cancer Center, Goyang, Korea
3Department of Biomedical and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
4Department of Preventive Medicine, Ewha Womans University College of Medicine, Seoul, Korea
5Graduate Program in System Health Science and Engineering, Ewha Womans University, Seoul, Korea
6Department of Pediatrics, Ewha Womans University College of Medicine, Seoul, Korea
7Department of Anatomy, Ewha Womans University College of Medicine, Seoul, Korea
8Department of Obstetrics and Gynecology, Ewha Womans University College of Medicine, Seoul, Korea
9Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea
10Department of Psychiatry, Ewha Womans University College of Medicine, Seoul, Korea
11Department of Occupational and Environmental Medicine, Ewha Womans University College of Medicine, Seoul, Korea
©2021, Korean Society of Epidemiology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
The authors have no conflicts of interest to declare for this study.
FUNDING
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2020R1F1A1062227).
AUTHOR CONTRIBUTIONS
Conceptualization: EAP, SJC, HL, YJK, EHH, HP. Data curation: EJC, UJK, HJP. Formal analysis: HAL, UJK, HJP. Funding acquisition: HP. Methodology: BP, JM, EAP, SJC, HSK, HL, YJK, YSH, EJK, EHH, HP. Project administration: HP. Visualization: HAL. Writing – original draft: HAL. Writing – review & editing: BP, JM, EJC, UJK, HJP, EAP, SJC, HSK, HL, YJK, YSH, EJK, EHH, HP.
Characteristics | At birth |
Follow-up examinations (yr) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
3 | 5 | 7 | 8 | 9 | 10 | 11 | 12 | 13-15 | ||
Boys | ||||||||||
No. of subjects | 487 | 236 | 202 | 161 | 199 | 200 | 123 | 133 | 116 | 122 |
Height (cm) | 49.4±2.4 | 97.8±4.5 | 112.2±5.3 | 124.4±5.7 | 130.3±5.6 | 135.0±5.7 | 139.1±6.0 | 145.8±6.1 | 152.5±7.8 | 162.8±7.0 |
Z-score of height | -0.2±1.3 | -0.5±1.2 | -0.2±1.2 | -0.2±1.1 | -0.1±1.1 | -0.2±1.0 | -0.5±1.0 | -0.3±0.9 | -0.3±1.1 | 0.0±0.9 |
Weight (kg) | 3.2±0.5 | 14.9±2.0 | 20.1±3.4 | 25.3±4.9 | 29.1±6.3 | 32.8±6.9 | 35.5±7.6 | 41.2±9.4 | 47.8±11.0 | 56.0±12.3 |
Z-score of weight | -0.3±1.2 | -0.7±1.3 | -0.2±1.3 | -0.4±1.2 | -0.3±1.2 | -0.3±1.1 | -0.4±1.1 | -0.3±1.1 | -0.1±1.1 | 0.1±1.1 |
BMI (kg/m2) | 13.2±1.3 | 15.5±1.4 | 15.9±1.8 | 16.2±2.2 | 17.0±2.7 | 17.8±2.8 | 18.2±3.1 | 19.2±3.2 | 20.4±3.4 | 21.1±3.8 |
Overweight2 | - | 12 (5.2) | 13 (6.4) | 11 (6.9) | 14 (7.1) | 16 (8.1) | 12 (9.8) | 11 (8.3) | 8 (7.7) | 5 (5.1) |
Obesity3 | - | 13 (5.7) | 16 (7.9) | 11 (6.9) | 18 (9.1) | 16 (8.1) | 7 (5.7) | 10 (7.5) | 13 (12.5) | 12 (12.1) |
SBP (mmHg) | 65.8±8.1 | 93.8±10.5 | 93.8±10.5 | 100.8±9.8 | 106.0±10.8 | 107.7±10.9 | 110.2±11.7 | 111.8±10.0 | 110.0±13.5 | 111.8±11.8 |
DBP (mmHg) | 39.2±8.0 | 60.2±9.6 | 59.2±6.6 | 58.4±6.7 | 61.1±6.9 | 63.1±6.6 | 69.8±8.9 | 69.6±8.4 | 68.7±8.3 | 68.3±9.2 |
High BP4 | - | - | - | 6 (3.8) | 4 (2.0) | 7 (3.5) | 4 (3.3) | 5 (3.8) | 4 (3.5) | 3 (2.5) |
Girls | ||||||||||
No. of subjects | 452 | 239 | 196 | 201 | 183 | 199 | 113 | 143 | 113 | 127 |
Height (cm) | 48.7±2.7 | 96.1±4.2 | 111.5±4.7 | 122.8±4.9 | 129.9±5.0 | 134.7±5.7 | 139.2±5.7 | 147.0±6.3 | 153.6±6.1 | 158.2±5.4 |
Z-score of height | -0.3±1.4 | -0.7±1.1 | 0.0±1.1 | -0.2±1.0 | 0.0±0.9 | -0.2±1.0 | -0.5±0.9 | -0.3±1.0 | 0.0±1.0 | 0.1±1.0 |
Weight (kg) | 3.1±0.5 | 14.3±1.7 | 19.4±2.8 | 23.9±4.1 | 28.2±5.3 | 31.4±5.9 | 34.8±7.2 | 40.3±7.6 | 46.3±8.5 | 51.1±8.3 |
Z-score of weight | -0.3±1.3 | -0.7±1.2 | -0.2±1.2 | -0.4±1.1 | -0.2±1.0 | -0.3±1.0 | -0.4±1.0 | -0.3±1.0 | 0.0±1.0 | 0.1±1.0 |
BMI (kg/m2) | 13.1±1.5 | 15.4±1.3 | 15.5±1.5 | 15.8±2.1 | 16.6±2.5 | 17.2±2.4 | 17.8±2.7 | 18.6±2.8 | 19.6±3.0 | 20.4±2.9 |
Overweight2 | - | 19 (8.2) | 11 (5.6) | 8 (4.0) | 13 (7.1) | 19 (9.6) | 9 (8.0) | 7 (4.9) | 13 (13.8) | 15 (11.8) |
Obesity3 | - | 11 (4.7) | 8 (4.1) | 10 (5.0) | 9 (4.9) | 7 (3.5) | 8 (7.1) | 9 (6.3) | 7 (7.5) | 9 (7.1) |
SBP (mmHg) | 68.2±9.4 | 93.5±9.5 | 98.5±9.4 | 99.1±10.1 | 103.1±11.4 | 105.6±10.6 | 109.8±10.8 | 111.6±11.0 | 108.9±11.5 | 108.7±11.1 |
DBP (mmHg) | 39.3±8.0 | 60.3±8.9 | 59.3±6.4 | 59.2±6.8 | 60.5±7.3 | 62.4±7.4 | 69.5±8.0 | 71.0±9.3 | 68.5±8.8 | 66.9±7.9 |
High BP4 | - | - | - | 1 (0.5) | 2 (1.1) | 5 (2.5) | 1 (0.9) | 2 (1.4) | 0 (0.0) | 2 (1.6) |
Values are presented as mean±standard deviation or number (%).
The sex- and age-specific Z-scores of height and weight were calculated based on the 2017 Korean Children and Adolescent National Growth Charts; Overweight and obesity were defined based on the 2017 Korean Children and Adolescent National Growth Charts; High BP was defined based on the 2007 Korean Children and Adolescent National Growth Charts.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure.
1 Numbers vary as a result of missing data.
2 Overweight: 85th ≤ BMI < 95th percentile.
3 Obesity: BMI ≥ 95th percentile or BMI ≥25.0 kg/m2.
4 High BP: SBP or DBP ≥ 90th percentile or SBP/DBP ≥120/80 mmHg.
Phenotype | At birth |
Follow-up examinations |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6 mo1 | 12 mo1 | 18 mo1 | 24 mo1 | 3 yr | 5 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13-15 yr | ||||
Questionnaires | ||||||||||||||||
Demographics | O2 | O2 | O2 | O2 | O | O | O | O | O | O | O | O | O | |||
Breastfeeding | O2 | O2 | O2 | O2 | O | O | O | O | O | - | - | - | - | |||
Physical activity | O2 | O2 | O2 | O2 | O | O | O | O | O | - | O | O | O | |||
Parental disease history (HTN, DM, stroke, etc.) | - | - | - | - | O | O | O | O | O | - | O | O | O | |||
Secondhand smoking | O2 | O2 | O2 | O2 | O | O | O | O | O | O | O | O | O | |||
K-CBCL | - | - | - | - | - | O | O | - | O | - | O2 | O | - | |||
Conners Hyperactivity Rating Scale | - | - | - | - | - | O | O | - | O | - | O | O | - | |||
ADHD | - | - | - | - | - | O | O | - | O | - | O | O | - | |||
CDI, STAI, and TAIC | - | - | - | - | - | - | - | - | O2 | - | O2 | O2 | - | |||
Pubertal status (Tanner stage) | - | - | - | - | - | - | O | O | O | O | O | O | O | |||
Nutrition survey | ||||||||||||||||
Diet (24-hr recall) | - | - | - | - | O | O2 | O | - | - | - | - | - | - | |||
Diet (FFQ) | - | - | - | - | - | O2 | O | O | O | O | O | O | O | |||
Eating behaviors | - | - | - | - | O | - | O | O | O | O | O | O | O | |||
Physical examination | ||||||||||||||||
Anthropometric | O2 | O2 | O2 | O2 | O | O | O | O | O | O | O | O | O | |||
Blood pressure | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Hand-grip strength | - | - | - | - | - | - | O | O | O | - | - | - | - | |||
Bone mineral density | - | - | - | - | - | O2 | - | O2 | O2 | - | - | - | - | |||
Body composition (muscle, % body fat, etc.) | - | - | - | - | O2 | O | O2 | O | O | - | - | - | - | |||
Bone age | - | - | - | - | - | - | O2 | O2 | O2 | - | - | - | - | |||
Carotid intima-media thickness | - | - | - | - | - | - | - | - | - | - | - | - | O | |||
Blood | ||||||||||||||||
Chemistries | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Liver enzymes (gamma-glutamyl transferase) | - | - | - | - | - | - | - | - | - | O | O | O | O | |||
Persistent organic pollutants | - | - | - | - | - | - | O2 | O2 | O2 | - | - | - | - | |||
Lipids (total cholesterol, triglyceride, high-density lipoprotein cholesterol) | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Glucose | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Insulin | - | - | - | - | O2 | O | O | O | O | O2 | O2 | - | O | |||
Uric acid | - | - | - | - | O2 | O | O | O | O | O | O | O | O | |||
Endothelial dysfunction (ICAM-1, VCAM-1) | - | - | - | - | - | - | - | - | - | - | - | - | O | |||
Inflammatory biomarkers (hs-CRP, IL-6) | - | - | - | - | O2 | O | O | O | O | - | - | - | O | |||
Sex hormones (luteinizing hormone, DHEA, androstenedione, testosterone, estradiol) | - | - | - | - | - | - | O | O2 | O2 | - | - | - | - | |||
Thyroid-stimulating hormone | - | - | - | - | - | - | O2 | O2 | O2 | O | O | O | O | |||
Free thyroxine (fT4) | - | - | - | - | - | - | O2 | O2 | O2 | O2 | O2 | O2 | - | |||
25-Hydroxyvitamin D | - | - | - | - | - | - | O | O | O | - | - | - | - | |||
Oxidative stress | ||||||||||||||||
8-OHdG | - | - | - | - | O2 | O2 | O2 | - | - | - | - | - | - | |||
MDA | - | - | - | - | O2 | O2 | O2 | - | - | - | - | - | - | |||
Vitamins | ||||||||||||||||
Vitamin C | - | - | - | - | O2 | - | - | - | - | - | - | - | - | |||
Retinol | - | - | - | - | O2 | - | - | - | - | - | - | - | - | |||
Tocopherol | - | - | - | - | O2 | - | - | - | - | - | - | - | - | |||
Carotene | - | - | - | - | O2 | - | - | - | - | - | - | - | - | |||
Methylation | ||||||||||||||||
Proopiomelanocortin | - | - | - | - | - | - | O2 | O2 | O2 | - | - | - | - | |||
Hepatocyte nuclear factor 4 alpha | - | - | - | - | - | - | O2 | O2 | O2 | - | - | - | - | |||
Melanocortin 4 receptor | - | - | - | - | - | - | O2 | O2 | O2 | - | - | - | - | |||
Urine | ||||||||||||||||
Cotinine | - | - | - | - | O2 | O | O | - | - | - | - | - | - | |||
Bisphenol A | - | - | - | - | O | O | O | O2 | O | - | - | - | - | |||
Phthalate metabolites | - | - | - | - | O2 | O2 | O2 | O2 | O2 | - | - | - | - | |||
Single-nucleotide polymorphisms | Glutathione S-transferase T1 | |||||||||||||||
Glutathione S-transferase M1 | ||||||||||||||||
Angiotensin-converting enzyme rs4341 | ||||||||||||||||
Paraoxonase 1 rs662 | ||||||||||||||||
Myeloperoxidase rs2333227 | ||||||||||||||||
Peroxisome proliferator-activated receptor gamma rs1801282 | ||||||||||||||||
Fat mass and obesity‐associated rs9939609 | ||||||||||||||||
Solute carrier family 2 facilitated glucose transporter member 9 rs16890979 | ||||||||||||||||
Solute carrier family 22 member 12 rs3825017 |
HTN, hypertension; DM, diabetes mellitus; K-CBCL, Korean-Childhood Behavioral Checklist; ADHD, attention deficit hyperactivity disorder; CDI, Children’s Depression Inventory; STAI, State-Trait Anxiety Inventory; TAIC, Trait Anxiety Inventory for Children; FFQ, food frequency questionnaire; ICAM-1, intercellular adhesion molecule; VCAM-1, vascular cell adhesion molecule 1; hs-CRP, high-sensitivity C-reactive protein; IL, Interleukin; DHEA, dehydroepiandrosterone; MDA, malondialdehyde, 8-OHdG, 8-hydroxy-2′-deoxyguanosine.
1 Follow-up examinations were conducted by mail.
2 Only a portion of the subjects was measured.
Characteristics | At birth | Follow-up examinations (yr) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
3 | 5 | 7 | 8 | 9 | 10 | 11 | 12 | 13-15 | ||
Boys | ||||||||||
No. of subjects | 487 | 236 | 202 | 161 | 199 | 200 | 123 | 133 | 116 | 122 |
Height (cm) | 49.4±2.4 | 97.8±4.5 | 112.2±5.3 | 124.4±5.7 | 130.3±5.6 | 135.0±5.7 | 139.1±6.0 | 145.8±6.1 | 152.5±7.8 | 162.8±7.0 |
Z-score of height | -0.2±1.3 | -0.5±1.2 | -0.2±1.2 | -0.2±1.1 | -0.1±1.1 | -0.2±1.0 | -0.5±1.0 | -0.3±0.9 | -0.3±1.1 | 0.0±0.9 |
Weight (kg) | 3.2±0.5 | 14.9±2.0 | 20.1±3.4 | 25.3±4.9 | 29.1±6.3 | 32.8±6.9 | 35.5±7.6 | 41.2±9.4 | 47.8±11.0 | 56.0±12.3 |
Z-score of weight | -0.3±1.2 | -0.7±1.3 | -0.2±1.3 | -0.4±1.2 | -0.3±1.2 | -0.3±1.1 | -0.4±1.1 | -0.3±1.1 | -0.1±1.1 | 0.1±1.1 |
BMI (kg/m2) | 13.2±1.3 | 15.5±1.4 | 15.9±1.8 | 16.2±2.2 | 17.0±2.7 | 17.8±2.8 | 18.2±3.1 | 19.2±3.2 | 20.4±3.4 | 21.1±3.8 |
Overweight |
- | 12 (5.2) | 13 (6.4) | 11 (6.9) | 14 (7.1) | 16 (8.1) | 12 (9.8) | 11 (8.3) | 8 (7.7) | 5 (5.1) |
Obesity |
- | 13 (5.7) | 16 (7.9) | 11 (6.9) | 18 (9.1) | 16 (8.1) | 7 (5.7) | 10 (7.5) | 13 (12.5) | 12 (12.1) |
SBP (mmHg) | 65.8±8.1 | 93.8±10.5 | 93.8±10.5 | 100.8±9.8 | 106.0±10.8 | 107.7±10.9 | 110.2±11.7 | 111.8±10.0 | 110.0±13.5 | 111.8±11.8 |
DBP (mmHg) | 39.2±8.0 | 60.2±9.6 | 59.2±6.6 | 58.4±6.7 | 61.1±6.9 | 63.1±6.6 | 69.8±8.9 | 69.6±8.4 | 68.7±8.3 | 68.3±9.2 |
High BP |
- | - | - | 6 (3.8) | 4 (2.0) | 7 (3.5) | 4 (3.3) | 5 (3.8) | 4 (3.5) | 3 (2.5) |
Girls | ||||||||||
No. of subjects | 452 | 239 | 196 | 201 | 183 | 199 | 113 | 143 | 113 | 127 |
Height (cm) | 48.7±2.7 | 96.1±4.2 | 111.5±4.7 | 122.8±4.9 | 129.9±5.0 | 134.7±5.7 | 139.2±5.7 | 147.0±6.3 | 153.6±6.1 | 158.2±5.4 |
Z-score of height | -0.3±1.4 | -0.7±1.1 | 0.0±1.1 | -0.2±1.0 | 0.0±0.9 | -0.2±1.0 | -0.5±0.9 | -0.3±1.0 | 0.0±1.0 | 0.1±1.0 |
Weight (kg) | 3.1±0.5 | 14.3±1.7 | 19.4±2.8 | 23.9±4.1 | 28.2±5.3 | 31.4±5.9 | 34.8±7.2 | 40.3±7.6 | 46.3±8.5 | 51.1±8.3 |
Z-score of weight | -0.3±1.3 | -0.7±1.2 | -0.2±1.2 | -0.4±1.1 | -0.2±1.0 | -0.3±1.0 | -0.4±1.0 | -0.3±1.0 | 0.0±1.0 | 0.1±1.0 |
BMI (kg/m2) | 13.1±1.5 | 15.4±1.3 | 15.5±1.5 | 15.8±2.1 | 16.6±2.5 | 17.2±2.4 | 17.8±2.7 | 18.6±2.8 | 19.6±3.0 | 20.4±2.9 |
Overweight |
- | 19 (8.2) | 11 (5.6) | 8 (4.0) | 13 (7.1) | 19 (9.6) | 9 (8.0) | 7 (4.9) | 13 (13.8) | 15 (11.8) |
Obesity |
- | 11 (4.7) | 8 (4.1) | 10 (5.0) | 9 (4.9) | 7 (3.5) | 8 (7.1) | 9 (6.3) | 7 (7.5) | 9 (7.1) |
SBP (mmHg) | 68.2±9.4 | 93.5±9.5 | 98.5±9.4 | 99.1±10.1 | 103.1±11.4 | 105.6±10.6 | 109.8±10.8 | 111.6±11.0 | 108.9±11.5 | 108.7±11.1 |
DBP (mmHg) | 39.3±8.0 | 60.3±8.9 | 59.3±6.4 | 59.2±6.8 | 60.5±7.3 | 62.4±7.4 | 69.5±8.0 | 71.0±9.3 | 68.5±8.8 | 66.9±7.9 |
High BP |
- | - | - | 1 (0.5) | 2 (1.1) | 5 (2.5) | 1 (0.9) | 2 (1.4) | 0 (0.0) | 2 (1.6) |
Phenotype | At birth | Follow-up examinations |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6 mo |
12 mo |
18 mo |
24 mo |
3 yr | 5 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13-15 yr | ||||
Questionnaires | ||||||||||||||||
Demographics | O |
O |
O |
O |
O | O | O | O | O | O | O | O | O | |||
Breastfeeding | O |
O |
O |
O |
O | O | O | O | O | - | - | - | - | |||
Physical activity | O |
O |
O |
O |
O | O | O | O | O | - | O | O | O | |||
Parental disease history (HTN, DM, stroke, etc.) | - | - | - | - | O | O | O | O | O | - | O | O | O | |||
Secondhand smoking | O |
O |
O |
O |
O | O | O | O | O | O | O | O | O | |||
K-CBCL | - | - | - | - | - | O | O | - | O | - | O |
O | - | |||
Conners Hyperactivity Rating Scale | - | - | - | - | - | O | O | - | O | - | O | O | - | |||
ADHD | - | - | - | - | - | O | O | - | O | - | O | O | - | |||
CDI, STAI, and TAIC | - | - | - | - | - | - | - | - | O |
- | O |
O |
- | |||
Pubertal status (Tanner stage) | - | - | - | - | - | - | O | O | O | O | O | O | O | |||
Nutrition survey | ||||||||||||||||
Diet (24-hr recall) | - | - | - | - | O | O |
O | - | - | - | - | - | - | |||
Diet (FFQ) | - | - | - | - | - | O |
O | O | O | O | O | O | O | |||
Eating behaviors | - | - | - | - | O | - | O | O | O | O | O | O | O | |||
Physical examination | ||||||||||||||||
Anthropometric | O |
O |
O |
O |
O | O | O | O | O | O | O | O | O | |||
Blood pressure | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Hand-grip strength | - | - | - | - | - | - | O | O | O | - | - | - | - | |||
Bone mineral density | - | - | - | - | - | O |
- | O |
O |
- | - | - | - | |||
Body composition (muscle, % body fat, etc.) | - | - | - | - | O |
O | O |
O | O | - | - | - | - | |||
Bone age | - | - | - | - | - | - | O |
O |
O |
- | - | - | - | |||
Carotid intima-media thickness | - | - | - | - | - | - | - | - | - | - | - | - | O | |||
Blood | ||||||||||||||||
Chemistries | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Liver enzymes (gamma-glutamyl transferase) | - | - | - | - | - | - | - | - | - | O | O | O | O | |||
Persistent organic pollutants | - | - | - | - | - | - | O |
O |
O |
- | - | - | - | |||
Lipids (total cholesterol, triglyceride, high-density lipoprotein cholesterol) | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Glucose | - | - | - | - | O | O | O | O | O | O | O | O | O | |||
Insulin | - | - | - | - | O |
O | O | O | O | O |
O |
- | O | |||
Uric acid | - | - | - | - | O |
O | O | O | O | O | O | O | O | |||
Endothelial dysfunction (ICAM-1, VCAM-1) | - | - | - | - | - | - | - | - | - | - | - | - | O | |||
Inflammatory biomarkers (hs-CRP, IL-6) | - | - | - | - | O |
O | O | O | O | - | - | - | O | |||
Sex hormones (luteinizing hormone, DHEA, androstenedione, testosterone, estradiol) | - | - | - | - | - | - | O | O |
O |
- | - | - | - | |||
Thyroid-stimulating hormone | - | - | - | - | - | - | O |
O |
O |
O | O | O | O | |||
Free thyroxine (fT4) | - | - | - | - | - | - | O |
O |
O |
O |
O |
O |
- | |||
25-Hydroxyvitamin D | - | - | - | - | - | - | O | O | O | - | - | - | - | |||
Oxidative stress | ||||||||||||||||
8-OHdG | - | - | - | - | O |
O |
O |
- | - | - | - | - | - | |||
MDA | - | - | - | - | O |
O |
O |
- | - | - | - | - | - | |||
Vitamins | ||||||||||||||||
Vitamin C | - | - | - | - | O |
- | - | - | - | - | - | - | - | |||
Retinol | - | - | - | - | O |
- | - | - | - | - | - | - | - | |||
Tocopherol | - | - | - | - | O |
- | - | - | - | - | - | - | - | |||
Carotene | - | - | - | - | O |
- | - | - | - | - | - | - | - | |||
Methylation | ||||||||||||||||
Proopiomelanocortin | - | - | - | - | - | - | O |
O |
O |
- | - | - | - | |||
Hepatocyte nuclear factor 4 alpha | - | - | - | - | - | - | O |
O |
O |
- | - | - | - | |||
Melanocortin 4 receptor | - | - | - | - | - | - | O |
O |
O |
- | - | - | - | |||
Urine | ||||||||||||||||
Cotinine | - | - | - | - | O |
O | O | - | - | - | - | - | - | |||
Bisphenol A | - | - | - | - | O | O | O | O |
O | - | - | - | - | |||
Phthalate metabolites | - | - | - | - | O |
O |
O |
O |
O |
- | - | - | - | |||
Single-nucleotide polymorphisms | Glutathione S-transferase T1 | |||||||||||||||
Glutathione S-transferase M1 | ||||||||||||||||
Angiotensin-converting enzyme rs4341 | ||||||||||||||||
Paraoxonase 1 rs662 | ||||||||||||||||
Myeloperoxidase rs2333227 | ||||||||||||||||
Peroxisome proliferator-activated receptor gamma rs1801282 | ||||||||||||||||
Fat mass and obesity‐associated rs9939609 | ||||||||||||||||
Solute carrier family 2 facilitated glucose transporter member 9 rs16890979 | ||||||||||||||||
Solute carrier family 22 member 12 rs3825017 |
Values are presented as mean±standard deviation or number (%). The sex- and age-specific Z-scores of height and weight were calculated based on the 2017 Korean Children and Adolescent National Growth Charts; Overweight and obesity were defined based on the 2017 Korean Children and Adolescent National Growth Charts; High BP was defined based on the 2007 Korean Children and Adolescent National Growth Charts. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure. Numbers vary as a result of missing data. Overweight: 85th ≤ BMI < 95th percentile. Obesity: BMI ≥ 95th percentile or BMI ≥25.0 kg/m2. High BP: SBP or DBP ≥ 90th percentile or SBP/DBP ≥120/80 mmHg.
HTN, hypertension; DM, diabetes mellitus; K-CBCL, Korean-Childhood Behavioral Checklist; ADHD, attention deficit hyperactivity disorder; CDI, Children’s Depression Inventory; STAI, State-Trait Anxiety Inventory; TAIC, Trait Anxiety Inventory for Children; FFQ, food frequency questionnaire; ICAM-1, intercellular adhesion molecule; VCAM-1, vascular cell adhesion molecule 1; hs-CRP, high-sensitivity C-reactive protein; IL, Interleukin; DHEA, dehydroepiandrosterone; MDA, malondialdehyde, 8-OHdG, 8-hydroxy-2′-deoxyguanosine. Follow-up examinations were conducted by mail. Only a portion of the subjects was measured.